Jonathan Gillis - SEC Form 4 Insider Trading Activity
Summary
Updated Aug 3, 2026
Jonathan Gillis has filed 1 SEC Form 4 filing across 1 company in the last 90 days - selling. Lifetime open-market sales: $3.56M.
Profile
Jonathan Gillis is a corporate insider at MapLight Therapeutics, Inc. (MPLT). Gillis has reported 6 insider filings with the SEC since 2025. The most recent filing was in July 2026.
| Role | CAO and Interim CFO |
|---|---|
| Notability | 20/100 |
Board memberships
- MapLight Therapeutics, Inc.
Trading Pattern
InsiderAlpha's records for Jonathan Gillis go back to 2025: 6 primary Form 4 filings, an average of 3.0 per year. 12 recorded transactions carry a Rule 10b5-1 flag, meaning they were pre-scheduled under a written trading plan rather than discretionary.
Career & Filing History
Every role Jonathan Gillis has reported on a Form 4, reconstructed from the filings themselves - reporting insiders must state their relationship to the issuer (officer title, director seat, or 10% ownership) on every filing.
- CAO and Interim CFO at MapLight Therapeutics, Inc. (MPLT) - 1 filing, 2026
- CAAO and PAO at MapLight Therapeutics, Inc. (MPLT) - 5 filings, 2025 to 2026
Recent Transactions
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-20 | MPLT | MapLight Therapeutics, Inc. | S - Open-market sale [10b5-1] | 900 | $38.17 | $34K |
| 2026-07-20 | MPLT | MapLight Therapeutics, Inc. | S - Open-market sale [10b5-1] | 17.0K | $37.61 | $638K |
| 2026-07-20 | MPLT | MapLight Therapeutics, Inc. | S - Open-market sale [10b5-1] | 600 | $36.51 | $22K |
| 2026-07-20 | MPLT | MapLight Therapeutics, Inc. | S - Open-market sale [10b5-1] | 1.5K | $37.44 | $55K |
| 2026-07-20 | MPLT | MapLight Therapeutics, Inc. | S - Open-market sale [10b5-1] | 7.0K | $36.66 | $256K |
| 2026-07-20 | MPLT | MapLight Therapeutics, Inc. | S - Open-market sale [10b5-1] | 4.7K | $36.94 | $174K |
| 2026-07-20 | MPLT | MapLight Therapeutics, Inc. | S - Open-market sale [10b5-1] | 5.4K | $36.13 | $194K |
| 2026-04-29 | MPLT | MapLight Therapeutics, Inc. | S - Open-market sale [10b5-1] | 700 | $30.83 | $22K |
| 2026-04-29 | MPLT | MapLight Therapeutics, Inc. | S - Open-market sale [10b5-1] | 17.2K | $30.33 | $523K |
| 2026-04-29 | MPLT | MapLight Therapeutics, Inc. | S - Open-market sale [10b5-1] | 14.4K | $30.46 | $437K |
| 2026-04-29 | MPLT | MapLight Therapeutics, Inc. | S - Open-market sale [10b5-1] | 29.6K | $29.60 | $877K |
| 2026-04-29 | MPLT | MapLight Therapeutics, Inc. | S - Open-market sale [10b5-1] | 7.9K | $28.94 | $229K |
| 2026-04-17 | MPLT | MapLight Therapeutics, Inc. | S - Open-market sale | 3.6K | $26.61 | $96K |
| 2026-02-09 | MPLT | MapLight Therapeutics, Inc. | A - Grant or award | 6.0K | $0.00 | |
| 2026-01-27 | MPLT | MapLight Therapeutics, Inc. | F - Tax withholding / forfeiture | 22.1K | $17.98 | $396K |
| 2025-10-28 | MPLT | MapLight Therapeutics, Inc. | A - Grant or award | 30.6K | $0.00 |
Companies - Last 90 Days
- MapLight Therapeutics, Inc. (MPLT) - 1 filing, last 2026-07-20
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades at the companies Jonathan Gillis has recently filed at. Multiple unrelated insiders buying the same stock within a short window - cluster buying - has historically been one of the strongest Form 4 signals.
- Catalyst4, Inc. - $107.81M of MPLT open-market activity in the last 12 months
- Novo Holdings A/S - $16.20M of MPLT open-market activity in the last 12 months
- Christopher A. Kroeger - $12.54M of MPLT open-market activity in the last 12 months
- Erin Pennock Foff - $3.38M of MPLT open-market activity in the last 12 months
- Anatol Kreitzer - $2.78M of MPLT open-market activity in the last 12 months
- James Woodruff Lillie - $2.28M of MPLT open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
- James Jones
- Andrew T. Kaplan
- A. J. Kazimi
- Michael John Kazley
- Kennedy Lewis Investment Holdings II LLC
- KENNEDY LEWIS MANAGEMENT LP
- James M. Kilts
- Richard D. Kinder
Frequently Asked Questions
Who is Jonathan Gillis?
Jonathan Gillis is a corporate insider at MapLight Therapeutics, Inc. (MPLT). Gillis has reported 6 insider filings with the SEC since 2025. The most recent filing was in July 2026.…
How many SEC Form 4 filings has Jonathan Gillis submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Jonathan Gillis been buying or selling stock?
Recorded transactions: 0 open-market purchases and 13 open-market sales ($3.56M) across all tracked filings.
Where can I see all of Jonathan Gillis's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Open the live Jonathan Gillis profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.